Taishi Akimoto
Papers
2
Total Citations
33
H-Index
2
About
Taishi Akimoto is a leading figure in the advancement of minimally invasive gynecologic oncology, with a primary focus on robotic-assisted surgery for endometrial cancer. His major contributions lie in the comparative evaluation of next-generation robotic platforms, specifically the da Vinci Xi™ and da Vinci SP™ systems. In his highly cited 2024 study on early-stage endometrial cancer, Akimoto demonstrated the feasibility and comparable surgical outcomes of both systems for hysterectomy, critically showing no significant difference in postoperative recurrence or survival rates when performed without lymph node dissection. This work, alongside his broader analysis of three new robotic surgical systems, has provided crucial evidence for surgeons selecting platforms, emphasizing patient safety and oncologic efficacy. With these papers already garnering over 30 citations within their first year, Akimoto’s research is rapidly shaping clinical protocols and device adoption. His work is particularly notable for its focus on optimizing surgical precision while minimizing invasiveness, directly impacting recovery and quality of life for patients with gynecologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2